UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031775
Receipt number R000036274
Scientific Title A study of facial emotion recognition ability and attentional characteristics in adults with developmental disorders
Date of disclosure of the study information 2018/03/17
Last modified on 2019/10/29 10:08:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of facial emotion recognition ability and attentional characteristics in adults with developmental disorders

Acronym

A study of facial emotion recognition ability and attentional characteristics in developmental disorders

Scientific Title

A study of facial emotion recognition ability and attentional characteristics in adults with developmental disorders

Scientific Title:Acronym

A study of facial emotion recognition ability and attentional characteristics in developmental disorders

Region

Japan


Condition

Condition

Individuals with autism spectrum disorder, Individuals with attention deficits hyperactivity disorder, and healthy adults

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate facial emotion recognition ability and attentional characteristics in individuals with ASD, those with ADHD, and healthy adults.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Behavioral tests

Key secondary outcomes

Questionnaires


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Diagnosis

Type of intervention

Behavior,custom

Interventions/Control_1

Behavioral tests

Interventions/Control_2

Behavioral tests

Interventions/Control_3

Behavioral tests

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

ASD group
1) Subjects who had received a clinical diagnosis of ASD in outpatient units of the Showa University Karasuyama Hospital.
2) Aged 20-49 years-old, male and female
3) No serious comorbid psychiatric disorders or medical illness.
4) Capability of informed consent

ADHD group
1) Subjects who had received a clinical diagnosis of ADHD in outpatient units of the Showa University Karasuyama Hospital.
2) Aged 20-49 years-old, male and female
3) No serious comorbid psychiatric disorders or medical illness.
4) Capability of informed consent

Healthy group
1) Aged 20-49 years-old, male and female
2) No serious psychiatric disorders or medical illness.
3) Capability of informed consent

Key exclusion criteria

Subjects who are judged as unsuitable for participation in this study

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Itahashi

Organization

Showa University

Division name

Medical Institute of Developmental Disabilities Research

Zip code


Address

6-11-11 Kita-karasuyama, Setagaya-ku, Tokyo, Japan

TEL

03-5315-9357

Email

ita3@med.showa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takashi Itahashi

Organization

Showa University

Division name

Medical Institute of Developmental Disabilities Research

Zip code


Address

6-11-11 Kita-karasuyama, Setagaya-ku, Tokyo, Japan

TEL

03-5315-9357

Homepage URL


Email

ita3@med.showa-u.ac.jp


Sponsor or person

Institute

Medical Institute of Developmental Disabilities Research, Showa university

Institute

Department

Personal name



Funding Source

Organization

Japan society for the promotion of science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 03 Month 20 Day

Date of IRB

2017 Year 05 Month 09 Day

Anticipated trial start date

2018 Year 03 Month 30 Day

Last follow-up date

2019 Year 03 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 17 Day

Last modified on

2019 Year 10 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036274


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name